mesalamine has been researched along with Proteinuria in 11 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Proteinuria: The presence of proteins in the urine, an indicator of KIDNEY DISEASES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A randomized, 2-way, crossover study was conducted in 30 volunteers to compare the pharmacokinetic profile of a new once-daily dosing regimen of mesalazine (1 x 4 g/d) with the current twice-daily dosage (2 x 2 g/d) used in many European countries." | 2.73 | Is once-daily mesalazine equivalent to the currently used twice-daily regimen? A study performed in 30 healthy volunteers. ( Gandia, P; Houin, G; Idier, I, 2007) |
| "Patients with ulcerative colitis have a higher rate of tubular nephropathies." | 2.72 | [Characterization of proteinuria in patients with ulcerative colitis and therapy with aminosalicylates]. ( Aymaz, S; Buschhausen, L; Krakamp, B; Kruis, W; Weber, M, 2006) |
| "Tubular proteinuria is an extra-intestinal manifestation of inflammatory bowel disease irrespective of 5-ASA treatment." | 2.70 | Renal tubular injury is present in acute inflammatory bowel disease prior to the introduction of drug therapy. ( Fraser, JS; Lamb, EJ; Muller, AF; Newman, DJ; Smith, DJ, 2001) |
| "In an uncontrolled trial, patients with IgA nephropathy (IgAN) were treated with drugs that can alter the intestinal mucosal permeability to food antigens." | 2.67 | Low doses of drugs able to alter intestinal mucosal permeability to food antigens (5-aminosalicylic acid and sodium cromoglycate) do not reduce proteinuria in patients with IgA nephropathy: a preliminary noncontrolled trial. ( Arrigo, G; Bazzi, C; D'Amico, G; Petrini, C; Ragni, A; Rizza, V; Sinico, RA; Torpia, R, 1992) |
| "At least 1% of patients with Crohn's disease develop amyloidosis." | 2.45 | Crohn's disease and secondary amyloidosis: early complication? A case report and review of the literature. ( Basturk, T; Kusaslan, R; Ozagari, A; Ozturk, T; Unsal, A, 2009) |
| "The renal biopsy was performed and IgA nephropathy (type IV) was diagnosed." | 1.35 | [Crohn's disease in association with IgA nephropathy]. ( Choi, YJ; Chung, WC; Kim, HW; Lee, JM; Lee, JR; Lee, KM; Paik, CN; Yang, JM, 2008) |
| "Microproteinuria is mainly associated with UC and its activity but not affected by 5-ASA." | 1.33 | Microproteinuria in patients with inflammatory bowel disease: is it associated with the disease activity or the treatment with 5-aminosalicylic acid? ( Archimandritis, A; Dandakis, DC; Georgouli, A; Goumas, KE; Panagiotaki, M; Poulou, AC; Soutos, DC; Tyrmpas, I, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 7 (63.64) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Guillo, L | 1 |
| D'Amico, F | 1 |
| Achit, H | 1 |
| Ayav, C | 1 |
| Guillemin, F | 1 |
| Danese, S | 1 |
| Frimat, L | 1 |
| Peyrin-Biroulet, L | 1 |
| Lee, JM | 1 |
| Lee, KM | 1 |
| Kim, HW | 1 |
| Chung, WC | 1 |
| Paik, CN | 1 |
| Lee, JR | 1 |
| Choi, YJ | 1 |
| Yang, JM | 1 |
| Basturk, T | 1 |
| Ozagari, A | 1 |
| Ozturk, T | 1 |
| Kusaslan, R | 1 |
| Unsal, A | 1 |
| Velciov, S | 1 |
| Gluhovschi, G | 1 |
| Sporea, I | 1 |
| Trandafirescu, V | 1 |
| Petrica, L | 1 |
| Bozdog, G | 1 |
| Gluhovschi, C | 1 |
| Bob, F | 1 |
| Gădălean, F | 1 |
| Buzaş, R | 1 |
| Bobu, M | 1 |
| Voicu, L | 1 |
| Poulou, AC | 1 |
| Goumas, KE | 1 |
| Dandakis, DC | 1 |
| Tyrmpas, I | 1 |
| Panagiotaki, M | 1 |
| Georgouli, A | 1 |
| Soutos, DC | 1 |
| Archimandritis, A | 1 |
| Buschhausen, L | 1 |
| Kruis, W | 2 |
| Aymaz, S | 1 |
| Weber, M | 1 |
| Krakamp, B | 1 |
| Gandia, P | 1 |
| Idier, I | 1 |
| Houin, G | 1 |
| Schreiber, S | 1 |
| Hämling, J | 1 |
| Zehnter, E | 1 |
| Howaldt, S | 1 |
| Daerr, W | 1 |
| Raedler, A | 1 |
| Russo, GE | 1 |
| Bauco, B | 1 |
| Bosco, M | 1 |
| Bonello, M | 1 |
| Bisciglia, MF | 1 |
| De Paola, A | 1 |
| Villatico Campbell, S | 1 |
| Fava, D | 1 |
| Vitaliano, E | 1 |
| Fraser, JS | 1 |
| Muller, AF | 1 |
| Smith, DJ | 1 |
| Newman, DJ | 1 |
| Lamb, EJ | 1 |
| Bazzi, C | 1 |
| Sinico, RA | 1 |
| Petrini, C | 1 |
| Rizza, V | 1 |
| Torpia, R | 1 |
| Arrigo, G | 1 |
| Ragni, A | 1 |
| D'Amico, G | 1 |
2 reviews available for mesalamine and Proteinuria
| Article | Year |
|---|---|
Kidney function monitoring to prevent 5-aminosalicylic acid nephrotoxicity: What the gastroenterologist should know.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Creatinine; Glomerular Filtration Rate | 2021 |
Crohn's disease and secondary amyloidosis: early complication? A case report and review of the literature.
Topics: Adult; Amyloidosis; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Colchicine; Crohn Disease; Dise | 2009 |
4 trials available for mesalamine and Proteinuria
| Article | Year |
|---|---|
[Characterization of proteinuria in patients with ulcerative colitis and therapy with aminosalicylates].
Topics: Acute Disease; Adolescent; Adult; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Col | 2006 |
Is once-daily mesalazine equivalent to the currently used twice-daily regimen? A study performed in 30 healthy volunteers.
Topics: Acetylglucosaminidase; Administration, Oral; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroi | 2007 |
Renal tubular injury is present in acute inflammatory bowel disease prior to the introduction of drug therapy.
Topics: Acetylglucosaminidase; Adult; Aged; Aged, 80 and over; Alpha-Globulins; Anti-Inflammatory Agents, No | 2001 |
Low doses of drugs able to alter intestinal mucosal permeability to food antigens (5-aminosalicylic acid and sodium cromoglycate) do not reduce proteinuria in patients with IgA nephropathy: a preliminary noncontrolled trial.
Topics: Adult; Aminosalicylic Acids; Antigens; Cromolyn Sodium; Female; Food; Glomerulonephritis, IGA; Human | 1992 |
5 other studies available for mesalamine and Proteinuria
| Article | Year |
|---|---|
[Crohn's disease in association with IgA nephropathy].
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Antimetabo | 2008 |
Asymptomatic urinary anomalies, hematuria and proteinuria, in patients with inflammatory bowel disease. Preliminary study.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Crohn Disease; Diagnosis, Diffe | 2011 |
Microproteinuria in patients with inflammatory bowel disease: is it associated with the disease activity or the treatment with 5-aminosalicylic acid?
Topics: Adolescent; Adult; Aged; Colitis, Ulcerative; Creatinine; Crohn Disease; Female; Humans; Inflammator | 2006 |
Renal tubular dysfunction in patients with inflammatory bowel disease treated with aminosalicylate.
Topics: Adult; Alkaline Phosphatase; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Dose-Res | 1997 |
Pyelonephritis caused by mesalazine.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Blood Cell Count; Blood Sedimentation; Hematuria; Hu | 2000 |